ECR logo

Ercros Stock Price

Symbol: BME:ECRMarket Cap: €283.0mCategory: Materials

ECR Share Price Performance

ECR Community Fair Values

    Recent ECR News & Updates

    No updates

    Ercros, S.A. Key Details

    €655.7m

    Revenue

    €470.0m

    Cost of Revenue

    €185.8m

    Gross Profit

    €228.1m

    Other Expenses

    -€42.3m

    Earnings

    Last Reported Earnings
    Jun 30, 2025
    Next Reporting Earnings
    n/a
    Earnings per share (EPS)
    -0.46
    Gross Margin
    28.33%
    Net Profit Margin
    -6.45%
    Debt/Equity Ratio
    69.9%

    Ercros, S.A. Competitors

     
     
     
     
     
     
     
     
     
     
     
     

    About ECR

    Founded
    1817
    Employees
    1318
    CEO
    Antonio Zabalza Marti
    WebsiteView website
    www.ercros.es

    Ercros, S.A. manufactures and sells basic chemicals, intermediate chemicals, and pharmaceuticals in Spain. It operates through three segments: Chlorine Derivatives, Intermediate Chemicals, and Pharmacy. The Chlorine Derivatives segment produces ammonia, bioplastics, caustic potash and soda, chlorine, chloroisocyanurates, dicalcium phosphate, dichloroethane, hydrochloric acid, hydrogen peroxide, potassium carbonate, PVC compounds, sodium chlorate and chlorite, sodium hypochlorite, and vinyl chloride monomers and polychloride. This segment’s products are used as intermediates in other industrial processes to purify and treat drinking and waste water; treat and maintain swimming pool water; bleach fabrics and paper; produce solvents, detergents, and strippers; manufacture printing inks and coloring; to produce compound feed and in cooling equipment. The Intermediate Chemicals segment provides formaldehyde, glues and resins, molding compunds, paraformaldehyde, pentaerythritol and dipentaerythritol, and sodium formate for manufacturing of particle, and decorative laminates and plywoods, as well as resins, paints, and varnishes in the furniture and decoration industry; sockets and switches in the electrical components sector; and tableware, and health and packaging items in the textile tanning industry. The Pharmacy division engages in the production of raw materials and pharmaceutical intermediate products from antibiotic, cholesterol-lowering, anti-ulcer, and anti-fungal agents. This segment’s products include amlodipine besylate, azithromycin, clarithromycin, erythromycins, famotidine, fosfomycin calcium and sodium, fosfomycin trometamol, and fusidic acid. The company is also involved in exporting activities. Ercros, S.A. was founded in 1817 and is headquartered in Barcelona, Spain.

    Spanish Market Performance

    • 7 Days: -1.2%
    • 3 Months: 3.4%
    • 1 Year: 25.2%
    • Year to Date: 16.6%
    Over the last 7 days, the market has dropped 1.2%, driven by a loss of 4.9% in the Consumer Discretionary sector. In the last year, the market is actually up 25%. Earnings are forecast to grow by 4.6% annually. Market details ›
    This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
    Continue reading